{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:40:36Z","timestamp":1777365636859,"version":"3.51.4"},"reference-count":80,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.dld.2008.02.026","type":"journal-article","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T20:44:23Z","timestamp":1208810663000},"page":"619-626","source":"Crossref","is-referenced-by-count":93,"title":["Helicobacter pylori infection: A clinical overview"],"prefix":"10.1016","volume":"40","author":[{"given":"A.","family":"Kandulski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Selgrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Malfertheiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2008.02.026_bib1","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","article-title":"Helicobacter pylori infection and the development of gastric cancer","volume":"345","author":"Uemura","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2008.02.026_bib2","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1093\/jnci\/95.7.E3","article-title":"Bacterial infections as a cause of cancer","volume":"95","author":"Correa","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.dld.2008.02.026_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jcp.47.5.436","article-title":"Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas","volume":"47","author":"Eidt","year":"1994","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.dld.2008.02.026_bib4","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/j.1572-0241.2005.00225.x","article-title":"Guidelines for the management of dyspepsia","volume":"100","author":"Talley","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.dld.2008.02.026_bib5","first-page":"CD001961","article-title":"Initial management strategies for dyspepsia","author":"Delaney","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2008.02.026_bib6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.026_bib7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/bmj.324.7344.1012","article-title":"Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial","volume":"324","author":"Chiba","year":"2002","journal-title":"Br Med J"},{"issue":"25","key":"10.1016\/j.dld.2008.02.026_bib8","first-page":"CD002096","article-title":"Eradication of Helicobacter pylori for non-ulcer dyspepsia","author":"Moayyedi","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2008.02.026_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002096","article-title":"Eradication of Helicobacter pylori for non-ulcer dyspepsia","author":"Moayyedi","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2008.02.026_bib10","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/bmj.303.6812.1238","article-title":"Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia","volume":"303","author":"Patchett","year":"1991","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2008.02.026_bib11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1469-0691.2003.00707.x","article-title":"Non-invasive techniques for the diagnosis of Helicobacter pylori infection","volume":"9","author":"Gatta","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.dld.2008.02.026_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/gut.48.3.287","article-title":"Blood, urine, stool, breath, money, and Helicobacter pylori","volume":"48","author":"Vaira","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.026_bib13","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1053\/gast.2002.33019","article-title":"Dyspepsia management in primary care: a decision analysis of competing strategies","volume":"122","author":"Spiegel","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.026_bib14","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1572-0241.2006.00673.x","article-title":"Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial","volume":"101","author":"Jarbol","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.026_bib15","first-page":"3554","article-title":"A human model of gastric carcinogenesis","volume":"48","author":"Correa","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.dld.2008.02.026_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/gut.49.1.2","article-title":"Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia","volume":"49","author":"Dixon","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.026_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00042737-199601000-00007","article-title":"Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease","volume":"88","author":"Schlemper","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.02.026_bib18","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(88)90929-4","article-title":"Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori","volume":"8626\u20138627","author":"Marshall","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2008.02.026_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2036.2004.01751.x","article-title":"Dyspeptic symptoms associated with Helicobacter pylori infection are influenced by strain and host specific factors","volume":"19","author":"Treiber","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.02.026_bib20","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1111\/j.1572-0241.2003.07584.x","article-title":"The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia","volume":"98","author":"Kearney","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.026_bib21","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/00042737-200110000-00018","article-title":"Six-year follow-up after successful triple therapy for Helicobacter pylori infection in patients with peptic ulcer disease","volume":"13","author":"van der Wouden","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.02.026_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(02)07273-2","article-title":"Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis","volume":"359","author":"Huang","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2008.02.026_bib23","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(97)04523-6","article-title":"Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers","volume":"350","author":"Chan","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2008.02.026_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(02)07272-0","article-title":"Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial","volume":"359","author":"Chan","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2008.02.026_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2036.2002.01169.x","article-title":"Current concepts in the management of Helicobacter pylori infection\u2014the Maastricht 2\u20132000 Consensus Report","volume":"16","author":"Malfertheiner","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.02.026_bib26","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(98)04206-8","article-title":"Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter eradication for lesion prevention","volume":"352","author":"Hawkey","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2008.02.026_bib27","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJM200103293441304","article-title":"Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen","volume":"344","author":"Chan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2008.02.026_bib28","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1365-2036.2003.01528.x","article-title":"Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebo-controlled trial","volume":"17","author":"Lai","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.02.026_bib29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1523-5378.2007.00543.x","article-title":"Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial","volume":"12","author":"de Leest","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2008.02.026_bib30","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/gut.2005.080754","article-title":"Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations","volume":"55","author":"Lanas","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.026_bib31","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/gut.46.5.615","article-title":"Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy","volume":"46","author":"Schenk","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.026_bib32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1523-5378.2000.00032.x","article-title":"Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression","volume":"5","author":"Moayyedi","year":"2000","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2008.02.026_bib33","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0889-8553(05)70100-X","article-title":"Helicobacter pylori and gastroesophageal reflux disease","volume":"28","author":"Metz","year":"1999","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.dld.2008.02.026_bib34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bmj.326.7392.737","article-title":"Prevalence of Helicobacter in patients with gastro-oesophageal reflux disease: systematic review","volume":"326","author":"Raghunath","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2008.02.026_bib35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/gut.45.2.181","article-title":"Corpus gastritis is protective against reflux oesophagitis","volume":"45","author":"El-Serag","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.026_bib36","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1572-0241.2000.01970.x","article-title":"Association of Helicobacter pylori genotype with gastroesophageal reflux disease and other upper gastrointestinal diseases","volume":"95","author":"Fallone","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.026_bib37","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/j.1572-0241.2003.07533.x","article-title":"The changing epidemiology of GERD: geography and Helicobacter pylori","volume":"98","author":"Graham","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.026_bib38","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1023\/A:1012783630913","article-title":"No protective role of Helicobacter pylori in the pathogenesis of reflux esophagitis in patients with duodenal or benign gastric ulcer in Korea","volume":"46","author":"Kim","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.02.026_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1365-2036.2003.01428.x","article-title":"Review article: Helicobacter pylori and reflux disease","volume":"17","author":"Sharma","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.02.026_bib40","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1023\/A:1012731614075","article-title":"Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998","volume":"46","author":"Xia","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.02.026_bib41","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1046\/j.1365-2036.2002.01285.x","article-title":"Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease\u2014results from a randomized trial programme","volume":"16","author":"Malfertheiner","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.02.026_bib42","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1053\/gast.2001.29332","article-title":"Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease","volume":"121","author":"Moayyedi","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.026_bib43","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/bmj.38082.626725.EE","article-title":"Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project","volume":"328","author":"Harvey","year":"2004","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2008.02.026_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/gut.53.1.12","article-title":"Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial","volume":"53","author":"Kuipers","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.026_bib45","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/1097-0142(19920901)70:5<1075::AID-CNCR2820700511>3.0.CO;2-1","article-title":"Malignant lymphomas of the upper gastrointestinal tract. Results of a prospective study in 103 patients","volume":"70","author":"Fischbach","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2008.02.026_bib46","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1096-9896(199602)178:2<122::AID-PATH486>3.0.CO;2-D","article-title":"Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue","volume":"178","author":"Hussell","year":"1996","journal-title":"J Pathol"},{"key":"10.1016\/j.dld.2008.02.026_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/path.1711690208","article-title":"Proliferation and differentiation of tumour cells from B-cell lymphoma of mucosa-associated lymphoid tissue in vitro","volume":"169","author":"Hussell","year":"1993","journal-title":"J Pathol"},{"key":"10.1016\/j.dld.2008.02.026_bib48","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1053\/gast.2000.19579","article-title":"Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group","volume":"119","author":"Fischbach","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.026_bib49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gut.53.1.34","article-title":"Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series","volume":"53","author":"Fischbach","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.026_bib50","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/annonc\/mdl498","article-title":"Estimates of the cancer incidence and mortality in Europe in 2006","volume":"18","author":"Ferlay","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.dld.2008.02.026_bib51","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc703","article-title":"Helicobacter pylori and gastrointestinal tract adenocarcinomas","volume":"2","author":"Peek","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.dld.2008.02.026_bib52","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.3748\/wjg.v13.i21.2901","article-title":"Diet, H. pylori infection and gastric cancer: evidence and controversies","volume":"13","author":"Rocco","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.026_bib53","first-page":"1","article-title":"Schistosomes, liver flukes and Helicobacter pylori","volume":"61","year":"1994","journal-title":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans"},{"key":"10.1016\/j.dld.2008.02.026_bib54","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0016-5085(98)70143-X","article-title":"Helicobacter pylori infection induces gastric cancer in mongolian gerbils","volume":"115","author":"Watanabe","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.026_bib55","first-page":"4255","article-title":"Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils","volume":"58","author":"Honda","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.dld.2008.02.026_bib56","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1053\/gast.2001.27999","article-title":"Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection","volume":"121","author":"Ekstrom","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.026_bib57","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.gastro.2003.08.033","article-title":"Meta-analysis of the relationship between cagA seropositivity and gastric cancer","volume":"125","author":"Huang","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.026_bib58","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/gut.2004.056549","article-title":"The time to eradicate gastric cancer is now","volume":"54","author":"Graham","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.026_bib59","first-page":"28","article-title":"Role of Helicobacter pylori in the pathogenesis of atrophic gastritis","volume":"223","author":"Kuipers","year":"1997","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.dld.2008.02.026_bib60","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1523-5378.2001.00042.x","article-title":"Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study","volume":"6","author":"Asaka","year":"2001","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2008.02.026_bib61","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1046\/j.1440-1746.2000.02305.x","article-title":"Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia","volume":"15","author":"Ohkuma","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.02.026_bib62","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1349-7006.2003.tb01426.x","article-title":"Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils","volume":"94","author":"Nozaki","year":"2003","journal-title":"Cancer Sci"},{"key":"10.1016\/j.dld.2008.02.026_bib63","first-page":"11","article-title":"A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication","volume":"116","author":"Zhou","year":"2003","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.dld.2008.02.026_bib64","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1158\/1055-9965.EPI-03-0124","article-title":"Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial","volume":"13","author":"Ley","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.dld.2008.02.026_bib65","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/gut.2005.072009","article-title":"Long term follow up of patients treated for Helicobacter pylori infection","volume":"54","author":"Mera","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.026_bib66","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jnci\/92.23.1881","article-title":"Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy","volume":"92","author":"Correa","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.dld.2008.02.026_bib67","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/jnci\/92.23.1868","article-title":"Preventing cancer by disrupting progression of precancerous lesions","volume":"92","author":"Blot","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.dld.2008.02.026_bib68","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/gut.2003.034629","article-title":"Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication","volume":"53","author":"Leung","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.026_bib69","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1111\/j.1572-0241.2005.41688.x","article-title":"Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art-critique","volume":"100","author":"Malfertheiner","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.026_bib70","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(05)60004-9","article-title":"Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori","volume":"352","author":"Gasbarrini","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2008.02.026_bib71","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2006-12-063222","article-title":"Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles","author":"Emilia","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.dld.2008.02.026_bib72","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1523-5378.2007.00477.x","article-title":"Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura","volume":"12","author":"Kodama","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2008.02.026_bib73","first-page":"1436","article-title":"Effects of a Helicobacter pylori eradication regimen on anti-platelet autoantibody response in infected and uninfected patients with idiopathic thrombocytopenic purpura","volume":"91","author":"Asahi","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.dld.2008.02.026_bib74","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bcmd.2006.09.006","article-title":"A hematologist's view of unexplained iron deficiency anemia in males: impact of Helicobacter pylori eradication","volume":"38","author":"Hershko","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.dld.2008.02.026_bib75","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cccn.2004.12.010","article-title":"Soluble transferrin receptor concentration is not superior to log ferritin for evaluating erythropoiesis in adolescents with iron deficiency anemia","volume":"355","author":"Choi","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.dld.2008.02.026_bib76","first-page":"435","article-title":"Sensitivity, specificity, and predictive value of serum soluble transferrin receptor at different stages of iron deficiency","volume":"35","author":"Choi","year":"2005","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.dld.2008.02.026_bib77","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archinte.167.8.821","article-title":"Inverse associations of Helicobacter pylori with asthma and allergy","volume":"167","author":"Chen","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.dld.2008.02.026_bib78","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00042737-200306000-00009","article-title":"Atopy, Helicobacter pylori and the hygiene hypothesis","volume":"15","author":"Cremonini","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.02.026_bib79","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1159\/000093816","article-title":"Respiratory diseases and Helicobacter pylori infection: is there a link?","volume":"73","author":"Roussos","year":"2006","journal-title":"Respiration"},{"key":"10.1016\/j.dld.2008.02.026_bib80","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jech.2006.046706","article-title":"Helicobacter pylori colonisation and eczema","volume":"61","author":"Herbarth","year":"2007","journal-title":"J Epidemiol Commun Health"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865808000856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865808000856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T17:23:05Z","timestamp":1546104185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865808000856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":80,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S1590865808000856"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2008.02.026","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}